News Center
Date：2026-04-28 Source：
On April 23, 2026, the Seminar on Independent Innovation and Development of Medical Equipment was held in Shanghai. The event brought together experts and industry leaders to explore pathways for localization and innovation in medical equipment.
Mr. Kevin Huang, Founder and CEO of Shanghai Maxflex Medical Technology Co., Ltd., was invited to attend and delivered a keynote presentation titled:
“Localization of Clear Aligner Materials — A Methodological Study from R&D to Industrial Implementation.”
His presentation shared practical, end-to-end experience covering the full lifecycle of clear aligner materials—from research and development to industrial-scale implementation.
During the seminar, Mr. Huang focused on the localization of clear aligner materials and presented a systematic methodology covering the full journey from R&D to project implementation.
Starting from in-depth market insights, his framework integrates pain point analysis, opportunity identification, STP strategy, and Porter’s Five Forces model to form a comprehensive market evaluation. This is followed by feasibility assessments across three key dimensions—technology, business, and regulatory compliance.
He also outlined resource allocation strategies balancing outsourcing and in-house production, emphasizing the importance of securing core processes while effectively isolating risks. Through MVP development and a rapid iterative model (PDCFA), a practical, scalable, and replicable localization pathway is established.
Mr. Huang emphasized that the key to successful localization in medical devices lies in:
“Defining direction with a researcher’s mindset and ensuring execution with an engineer’s discipline.”
He summarized the core framework as:
Two essential principles were also highlighted:
This structured methodology provides a clear and actionable roadmap for the localization of medical materials and received strong recognition from attendees.
During the panel discussion, Mr. Huang joined industry experts and enterprise representatives to discuss:
“From Plastics to Medical Applications: How Localization Can Bring Greater Certainty to Substitution, Mass Production, and Regulatory Approval.”
The discussion focused on four critical stages: Material R&D, Component processing, Medical device productization,Industrialization of combination products
Key topics included the real barriers to localization, consistency challenges in mass production, transition processes from imported to domestic materials, and core capabilities required within the medical supply chain.
As a high-tech enterprise dedicated to the clear aligner industry, Shanghai Maxflex Medical Technology Co., Ltd. has obtained international certifications including ISO 13485, CE, FDA, and GMP, and holds 34 patents.
With business operations spanning over 80 countries, Maxflex provides the industry with its MOSS one-stop solution, covering aligner materials, accessories, equipment, and full-process technical support.
Participation in this seminar highlights Maxflex’s technical strength and industry influence in the localization of clear aligner materials, further reinforcing its commitment to advancing high-end domestic medical materials through independent innovation.
Maxflex will continue to focus on the research and innovation of medical materials, strengthen collaboration across academia, industry, research, and healthcare, and overcome key technological barriers.
By accelerating the localization of clear aligner materials, Maxflex aims to deliver higher-quality products and technologies, contributing to the independent innovation and high-quality development of the medical equipment and device industry.
About Maxflex
Led by a team of passionate industry leading experts in material science, mechanical engineering, medical device and life science, Maxflex is an emerging, independent and fast-growing research, design and manufacturing enterprise dedicated to providing safe, efficient and innovative one-stop solutions for clear aligner therapy.
Ultimately, Maxflex improves the lives of more patients with better accessibility to state of art clear aligner therapy.
Business Inquiry
